Found 6 matching trials
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer PHASE2 This is a feasibility study to examine combination therapy with Trastuzumab...
Show More Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer PHASE2 RATIONALE: Vaccines made from gene-modified tumor cells may help the body b...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers PHASE1 RATIONALE: Vaccines made from gene-modified tumor cells may make the body b...
Show More Location
Glendale Memorial Hospital Comprehensive Cancer Center
Learn More & Join Trial
Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer PHASE1 RATIONALE: Vaccines made from a person's tumor cells may make the body buil...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer PHASE2 RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor grow...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer PHASE1 This phase I/II trial studies the side effects of a breast cancer vaccine (...
Show More Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Learn More & Join Trial